D M Gardner

Summary

Affiliation: Dalhousie University
Country: Canada

Publications

  1. ncbi Modern antipsychotic drugs: a critical overview
    David M Gardner
    Department of Psychiatry and College of Pharmacy, Dalhousie University, Halifax, NS
    CMAJ 172:1703-11. 2005
  2. ncbi Evidence review and clinical guidance for the use of ziprasidone in Canada
    David M Gardner
    Department of Psychiatry, Dalhousie University, Halifax, NS, Canada
    Ann Gen Psychiatry 12:1. 2013
  3. ncbi International consensus study of antipsychotic dosing
    David M Gardner
    Department of Psychiatry, Dalhousie University, Canada
    Am J Psychiatry 167:686-93. 2010
  4. ncbi Evidence-based decisions about herbal products for treating mental disorders
    David M Gardner
    Department of Psychiatry and College of Pharmacy, Dalhousie University, Halifax, NS
    J Psychiatry Neurosci 27:324-33. 2002
  5. ncbi A comparison of factors used by physicians and patients in the selection of antidepressant agents
    David M Gardner
    Department of Psychiatry and the College of Pharmacy, Dalhousie University, QEII HSC, AJLB 7517, 5909 Veterans Memorial Way, Halifax, Nova Scotia, Canada B3H 2E2
    Psychiatr Serv 58:34-40. 2007
  6. ncbi Direct-to-consumer prescription drug advertising in Canada: permission by default?
    David M Gardner
    Department of Psychiatry and the College of Pharmacy, Dalhousie University, Halifax, NS
    CMAJ 169:425-7. 2003
  7. ncbi Use of selective serotonin reuptake inhibitors and youth suicide: making sense from a confusing story
    Stan Kutcher
    Department of Psychiatry and the World Health Organization Pan American Health Organization Collaborating Center, Halifax, Canada
    Curr Opin Psychiatry 21:65-9. 2008
  8. ncbi Community pharmacist services for people with mental illnesses: preferences, satisfaction, and stigma
    Emily Black
    Department of Pharmacy, Capital District Health Authority, Halifax, Nova Scotia, Canada
    Psychiatr Serv 60:1123-7. 2009
  9. ncbi Data safety monitoring boards and other study methodologies that address subject safety in "high-risk" therapeutic trials in youths
    Carlo Carandang
    Department of Psychiatry, Dalhousie University, Halifax, Nova Scotia, Canada
    J Am Acad Child Adolesc Psychiatry 46:489-92. 2007
  10. ncbi Alternatives to atypical antipsychotics for the management of dementia-related agitation
    Michael J Passmore
    Department of Psychiatry, Division of Geriatric Psychiatry, University of British Columbia, Vancouver, British Columbia, Canada
    Drugs Aging 25:381-98. 2008

Detail Information

Publications12

  1. ncbi Modern antipsychotic drugs: a critical overview
    David M Gardner
    Department of Psychiatry and College of Pharmacy, Dalhousie University, Halifax, NS
    CMAJ 172:1703-11. 2005
    ....
  2. ncbi Evidence review and clinical guidance for the use of ziprasidone in Canada
    David M Gardner
    Department of Psychiatry, Dalhousie University, Halifax, NS, Canada
    Ann Gen Psychiatry 12:1. 2013
    ..Key challenges in practice include the need for dosing on a full stomach and managing its early onset adverse effect of restlessness. Addressing these issues are critical to its long-term success...
  3. ncbi International consensus study of antipsychotic dosing
    David M Gardner
    Department of Psychiatry, Dalhousie University, Canada
    Am J Psychiatry 167:686-93. 2010
    ..Potency equivalents for anti-psychotic drugs are required to guide clinical dosing and for designing and interpreting research studies. Available dosing guidelines are limited by the methods and data from which they were generated...
  4. ncbi Evidence-based decisions about herbal products for treating mental disorders
    David M Gardner
    Department of Psychiatry and College of Pharmacy, Dalhousie University, Halifax, NS
    J Psychiatry Neurosci 27:324-33. 2002
  5. ncbi A comparison of factors used by physicians and patients in the selection of antidepressant agents
    David M Gardner
    Department of Psychiatry and the College of Pharmacy, Dalhousie University, QEII HSC, AJLB 7517, 5909 Veterans Memorial Way, Halifax, Nova Scotia, Canada B3H 2E2
    Psychiatr Serv 58:34-40. 2007
    ..The authors therefore identified, valued, and ranked factors of antidepressant treatment selection that are relevant to patients and compared them with the opinions of general practitioners...
  6. ncbi Direct-to-consumer prescription drug advertising in Canada: permission by default?
    David M Gardner
    Department of Psychiatry and the College of Pharmacy, Dalhousie University, Halifax, NS
    CMAJ 169:425-7. 2003
  7. ncbi Use of selective serotonin reuptake inhibitors and youth suicide: making sense from a confusing story
    Stan Kutcher
    Department of Psychiatry and the World Health Organization Pan American Health Organization Collaborating Center, Halifax, Canada
    Curr Opin Psychiatry 21:65-9. 2008
    ..This review provides an update on use of selective serotonin reuptake inhibitors and youth suicide, and describes an informed examination of the social and professional dimensions of this issue...
  8. ncbi Community pharmacist services for people with mental illnesses: preferences, satisfaction, and stigma
    Emily Black
    Department of Pharmacy, Capital District Health Authority, Halifax, Nova Scotia, Canada
    Psychiatr Serv 60:1123-7. 2009
    ..The aim of this study was to determine patient preferences, satisfaction, and perceived stigma related to community pharmacists...
  9. ncbi Data safety monitoring boards and other study methodologies that address subject safety in "high-risk" therapeutic trials in youths
    Carlo Carandang
    Department of Psychiatry, Dalhousie University, Halifax, Nova Scotia, Canada
    J Am Acad Child Adolesc Psychiatry 46:489-92. 2007
  10. ncbi Alternatives to atypical antipsychotics for the management of dementia-related agitation
    Michael J Passmore
    Department of Psychiatry, Division of Geriatric Psychiatry, University of British Columbia, Vancouver, British Columbia, Canada
    Drugs Aging 25:381-98. 2008
    ..A comprehensive biopsychosocial assessment and treatment plan is likely the most effective way to manage DRA...
  11. ncbi Monitoring and management of metabolic risk factors in outpatients taking antipsychotic drugs: a controlled study
    Amber Jennex
    Pharmacy Department, Queen Elizabeth II Health Sciences Centre, Halifax, Nova Scotia
    Can J Psychiatry 53:34-42. 2008
    ....
  12. ncbi Psychotherapy and medication options for depression
    Allan Abbass
    Am Fam Physician 69:2071-2, 2074. 2004